Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

NCT03550313 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

565

Enrollment

INDUSTRY

Sponsor class

Stopped Study vaccinations and blood draws were halted due to adequacy of a smaller dataset and study feasibility issues. It was not based on any safety concerns.

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Multivalent
BIOLOGICAL: Prevnar 13

Sponsor

Pfizer